Responses
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – anti-TNF therapy
FRI0159 Long-term effectiveness and safety of adalimumab in patients with moderate versus severe rheumatoid arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.